Predicting efficacy and safety outcomes in patients with hepatitis C virus genotype 1 and persistently 'normal' alanine aminotransferase levels treated with peginterferon alpha-2a (40KD) plus ribavirin.
- DOI
- 10.1111/j.1478-3231.2007.01603.x
- Published
- 2008 Jan
- Container
- Liver international : official journal of the International Association for the Study of the Liver
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/j.1478-3231.2007.01603.x,
title = {Predicting efficacy and safety outcomes in patients with hepatitis C virus genotype 1 and persistently 'normal' alanine aminotransferase levels treated with peginterferon alpha-2a (40KD) plus ribavirin.},
author = {Snoeck E and Hadziyannis SJ and Puoti C and Swain MG and Berg T and Marcellin P and Zarski JP and Jorga K and Zeuzem S},
year = {2008},
journal = {Liver international : official journal of the International Association for the Study of the Liver},
doi = {10.1111/j.1478-3231.2007.01603.x},
url = {https://doi.org/10.1111/j.1478-3231.2007.01603.x}
}RIS
TY - JOUR TI - Predicting efficacy and safety outcomes in patients with hepatitis C virus genotype 1 and persistently 'normal' alanine aminotransferase levels treated with peginterferon alpha-2a (40KD) plus ribavirin. AU - Snoeck E AU - Hadziyannis SJ AU - Puoti C AU - Swain MG AU - Berg T AU - Marcellin P AU - Zarski JP AU - Jorga K AU - Zeuzem S PY - 2008 JO - Liver international : official journal of the International Association for the Study of the Liver DO - 10.1111/j.1478-3231.2007.01603.x UR - https://doi.org/10.1111/j.1478-3231.2007.01603.x ER -
APA
E, S., SJ, H., C, P., MG, S., T, B., P, M., JP, Z., K, J., & S, Z. (2008). Predicting efficacy and safety outcomes in patients with hepatitis C virus genotype 1 and persistently 'normal' alanine aminotransferase levels treated with peginterferon alpha-2a (40KD) plus ribavirin.. Liver international : official journal of the International Association for the Study of the Liver. https://doi.org/10.1111/j.1478-3231.2007.01603.x
Source records
- pubmed · retrieved 2026-09-27T07:32:41.765Z